Drug intelligence / Profile preview

DN-2024004

Development stage
Preclinical
Lead developer
Daehan Nupharm
Modality
Small Molecules
01

Overview

DN-2024004 is a small molecule drug candidate being developed by Daehan Nupharm, a South Korean pharmaceutical company, for the treatment of liver disease. Currently in the formulation development stage, the project is part of Daehan Nupharm's research and development pipeline, which focuses on metabolic and hepatic health. The company often specializes in developing improved management drugs (IMDs) and new formulations of existing compounds to enhance therapeutic efficacy or patient compliance. While the specific biological target and mechanism of action for DN-2024004 have not been publicly disclosed, the candidate aims to address unmet needs in liver health, potentially targeting conditions such as non-alcoholic fatty liver disease (NAFLD) or providing hepatoprotective effects.

Other names
DN-2024004-Daehan Nupharm-small molecule-Liver diseaseDN2024004-Daehan Nupharm-small molecule-Liver diseaseDN 2024004-Daehan Nupharm-small molecule-Liver disease

Beyond the preview

Go deeper on DN-2024004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DN-2024004.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call